Atlas Trials

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Clinical trial NCT02382913 · COMPLETED

Trial details

NCT number
NCT02382913
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pertussis
Start date
2015-04-01
Primary completion
2015-06-01
Enrollment
315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.